Global Primary Cells Market Size & Outlook, 2023-2030

The primary cells industry worldwide is expected to reach a projected revenue of US$ 3,997.4 million by 2030. A compound annual growth rate of 10.2% is expected of the worldwide primary cells industry from 2024 to 2030.
Revenue, 2023 (US$M)
$2,021.8
Forecast, 2030 (US$M)
$3,997.4
CAGR, 2024 - 2030
10.2%
Report Coverage
Worldwide

Global primary cells market highlights

  • The global primary cells market generated a revenue of USD 2,021.8 million in 2023 and is expected to reach USD 3,997.4 million by 2030.
  • The market is expected to grow at a CAGR (2024 - 2030) of 10.2% by 2030.
  • In terms of segment, human primary cells accounted for a revenue of USD 1,279.9 million in 2023.
  • Human Primary Cells is the most lucrative origin segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2023.
  • Country-wise, Kuwait is expected to register the highest CAGR from 2024 to 2030.

Global data book summary

Market revenue in 2023USD 2,021.8 million
Market revenue in 2030USD 3,997.4 million
Growth rate10.2% (CAGR from 2023 to 2030)
Largest segmentHuman primary cells
Fastest growing segmentHuman Primary Cells
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationHuman Primary Cells, Animal Primary Cells

Other key industry trends

  • In terms of revenue, the North America accounted for 36.1% of the global primary cells market in 2023.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, Kuwait is the fastest growing regional market and is projected to reach USD 9.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Primary Cells Market Companies

Name Profile # Employees HQ Website

Global primary cells market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to primary cells market will help companies and investors design strategic landscapes.


Human primary cells was the largest segment with a revenue share of 63.3% in 2023. Horizon Databook has segmented the Global primary cells market based on human primary cells, animal primary cells covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Primary Cells Origin Outlook (Revenue, USD Million, 2018-2030)
    • Human Primary Cells
    • Animal Primary Cells
  • Global Primary Cells Type Outlook (Revenue, USD Million, 2018-2030)
    • Hematopoietic Cells
    • Skeletal and Muscle Cells
    • Heart Cells
    • Hepatocytes
    • Renal Cells
    • Lung Cells
    • Gastrointestinal Cells
    • Skin Cells
    • Other Primary Cells
  • Global Primary Cells Application Outlook (Revenue, USD Million, 2018-2030)
    • Cancer Research
    • Regenerative Medicine
    • Drug Discovery and Development
    • Others
  • Global Primary Cells End-Use Outlook (Revenue, USD Million, 2018-2030)
    • Pharmaceuticals & Biotechnology companies
    • Academic & Research Institutes
    • CROs

Reasons to subscribe to Global primary cells market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global primary cells market databook

  • Our clientele includes a mix of primary cells market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global primary cells market , including forecasts for subscribers. This global databook contains high-level insights into Global primary cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global primary cells market size, by regions, 2018-2030 (US$M)

Top 10 countries: Primary cells market size, 2023 (US$M)

Global primary cells market share, by origin, 2023 & 2030 (%, US$M)

Primary cells market: Opportunity assessment by country

Global primary cells market, by region, 2023 (US$M)

Global primary cells market size, by regions, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more